Cargando…
Use of existing electronic health care databases to evaluate medication safety in pregnancy: Triptan exposure in pregnancy as a case study
PURPOSE: The recent expansion of electronic health and medical record systems may present an opportunity to generate robust post‐approval safety data and obviate the limitations of prospective pregnancy exposure registries. We examined and compared, over the same time frame, the outcomes of triptan...
Autores principales: | Yusuf, Akeem, Chia, Victoria, Xue, Fei, Mikol, Daniel D., Bollinger, Lisa, Cangialose, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586074/ https://www.ncbi.nlm.nih.gov/pubmed/30240072 http://dx.doi.org/10.1002/pds.4658 |
Ejemplares similares
-
Dihydroergotamine and triptan use to treat migraine during pregnancy and the risk of adverse pregnancy outcomes
por: Bérard, Anick, et al.
Publicado: (2021) -
Association of Maternal Use of Triptans During Pregnancy With Risk of Attention-Deficit/Hyperactivity Disorder in Offspring
por: Harris, Gerd Marie, et al.
Publicado: (2022) -
All triptans are not the same
por: Rapoport, Alan M., et al.
Publicado: (2001) -
Clinical experience with triptans
por: Zanchin, Giorgio, et al.
Publicado: (2001) -
Different characteristics of triptans
por: Pini, Luigi A., et al.
Publicado: (2004)